Bessler Robert 4

What Happened
Robert Bessler, a director of LifeStance Health Group, sold shares in open-market transactions on May 12, 2026. The filing shows two identical dispositions of 287,517 shares at $8.02 each (proceeds of $2,305,886 per entry), for a combined sale of 575,034 shares and aggregate proceeds of approximately $4,611,772. These were reported as sales (routine dispositions), not purchases.

Key Details

• Transaction date and price: 2026-05-12 — two sales of 287,517 shares at $8.02 each.
• Total sold: 575,034 shares; total proceeds ≈ $4,611,772.
• Shares owned after transaction: not specified in this filing.
• Footnotes: Reporting person disclaims beneficial ownership except to the extent of pecuniary interest (F1, F2). Shares are held of record by Alpine Glow Capital; Bessler is manager and sole member of Alpine Glow Capital and similarly disclaims beneficial ownership except for pecuniary interest (F3).
• Timeliness: Report filed May 14, 2026 for transactions on May 12, 2026 (filed promptly).

Context
These are outright sales reported by a director and, by themselves, do not indicate insider optimism the way purchases might. The filing’s disclaimers note that the shares are held of record by Alpine Glow Capital and that Bessler disclaims beneficial ownership except for any pecuniary interest, which can affect how to interpret control or intent. Retail investors should view insider sales as routine unless accompanied by other corporate developments.